Related Experiment Video

Updated: Apr 27, 2026

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment
11:11

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

Published on: January 24, 2020

9.6K

[Effect of CIAPIN1 gene on proliferation of K562 cells]

Ya-Ni Lin1, Jian Wang1, Qing-Hua Li1

  • 1State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Disease Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.

Zhongguo Shi Yan Xue Ye Xue Za Zhi
|July 4, 2014
PubMed

Insights

Inhibiting the CIAPIN1 gene significantly reduced chronic myeloid leukemia (CML) cell proliferation and tumor growth in K562 cells, both in vitro and in vivo.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Gene Expression Analysis

Context:

  • Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by uncontrolled proliferation of myeloid cells.
  • The CIAPIN1 gene's role in CML pathogenesis requires further elucidation.
  • Targeting specific genes offers a potential therapeutic strategy for CML.

Purpose:

  • To investigate the functional role of the CIAPIN1 gene in the proliferation of the K562 CML cell line.
  • To assess the effects of CIAPIN1 gene inhibition on K562 cell growth and tumorigenicity.
  • To evaluate CIAPIN1 as a potential therapeutic target in CML.

Summary:

  • The study constructed and utilized an shRNA eukaryotic expression vector to inhibit CIAPIN1 gene expression in K562 cells.
  • Real-time PCR and Western blot confirmed reduced CIAPIN1 expression.
  • MTT assays, colony-forming tests, and in vivo xenograft models demonstrated that CIAPIN1 inhibition significantly weakened K562 cell proliferation, colony formation, and tumorigenic potential.

Impact:

  • CIAPIN1 gene inhibition demonstrates a significant suppressive effect on K562 cell proliferation and tumorigenicity.
  • These findings suggest that CIAPIN1 is a critical factor in CML progression.
  • Targeting CIAPIN1 may represent a novel therapeutic approach for managing chronic myeloid leukemia.

More Related Videos

Analysis of Cell Cycle Position in Mammalian Cells12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

60.4K
A Co-culture Method to Investigate the Crosstalk Between X-ray Irradiated Caco-2 Cells and PBMC11:40

A Co-culture Method to Investigate the Crosstalk Between X-ray Irradiated Caco-2 Cells and PBMC

Published on: January 30, 2018

14.9K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

4.3K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.3K